US 10570214
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 10570214 (Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/47